CG Oncology Announces Pricing of Public Offering
Portfolio Pulse from
CG Oncology, Inc. has announced the pricing of its public offering of 8 million shares at $28.00 per share. The offering includes 7.3 million shares from the company and 700,000 shares from an existing stockholder.
December 13, 2024 | 1:30 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
CG Oncology has priced its public offering of 8 million shares at $28 per share, which includes 7.3 million shares from the company and 700,000 from an existing stockholder.
The public offering increases the number of shares available in the market, which can lead to a short-term decrease in stock price due to dilution. The offering price of $28 per share sets a benchmark for current market valuation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100